Currently, we are investigating CAR T cell therapy as a bridge to bone marrow transplant for leukemia and lymphoma patients and are unique in our research of CAR T in combination with transplant. (cityofhope.org)
The populations of some immune cell types, in particular T cells, are slow to recover following bone marrow transplant, but the reason for this is not known. (immunology.org)
This study is exploring how to improve bone marrow transplant procedures so the body better accepts donor stem cells. (nhlbi.nih.gov)